Novo Nordisk Makes Bold $5.2 Billion Move with Akero Buyout to Accelerate Liver Disease Breakthroughs
In a landmark deal marking a new era under CEO Mike Doustdar, Novo Nordisk acquires Akero Therapeutics for up to
Read MoreIn a landmark deal marking a new era under CEO Mike Doustdar, Novo Nordisk acquires Akero Therapeutics for up to
Read MoreRiyadh – Saudi Arabia’s healthcare sector is poised for another wave of growth and innovation, as new biotechnology and pharmaceutical
Read More“At this stage, details are limited, and a range of potential outcomes remain under discussion,” said Philips in a statement,
Read More